Sinride VM 1mg/500mg/0.2mg Tablet SR
Marketer
Indoscot Healthcare LLP
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)
Overview Sinride VM 1mg/500mg/0.2mg Tablet SR
Diabetic patients with type 2 mellitus may benefit from Glycadia XR 1mg/500mg/0.2mg tablets, an antidiabetic medication combining multiple agents. This formulation aids in regulating blood glucose levels in adults. Administer Glycadia XR with meals, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on your blood sugar response. Continued use, even with well-managed glucose levels, is crucial. Discontinuing without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication complements a comprehensive diabetes management plan incorporating diet, exercise, and weight management as recommended by your doctor. Common side effects include hypoglycemia (low blood sugar). Learn to recognize hypoglycemic symptoms like sweating, dizziness, headache, and tremors, and know how to treat them. Regular meals and carrying a readily available glucose source (e.g., sugary snacks, juice) are preventative measures. Alcohol consumption elevates hypoglycemia risk and should be limited. Other possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, edema, blurred vision, bone fractures, and upper respiratory infections. Weight gain may occur. Glycadia XR is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Individuals with a history of cardiovascular disease should inform their physician before initiating treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring is essential, and your doctor might recommend blood tests to monitor blood cell counts and liver function.
Uses of Sinride VM 1mg/500mg/0.2mg Tablet SR
Managing Type 2 diabetes
Major Benefits of Sinride VM 1mg/500mg/0.2mg Tablet SR:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Sinride VM 1mg/500mg/0.2mg SR tablets on an empty stomach.
Common Side effects of Sinride VM 1mg/500mg/0.2mg Tablet SR:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Sinride VM 1mg/500mg/0.2mg Tablet SR:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Sinride VM 1mg/500mg/0.2mg Extended-Release Tablets should be taken on an empty stomach.
How Sinride VM 1mg/500mg/0.2mg Tablet SR works:
Sinride VM extended-release tablets (1mg/500mg/0.2mg) contain a triple combination of antidiabetic agents.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Sinride VM 1mg/500mg/0.2mg SR tablets is unsafe.
PregnancyCONSULT YOUR DOCTOR
The use of Sinride VM 1mg/500mg/0.2mg Tablet SR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential advantages against any possible dangers prior to prescribing. Patient consultation with their doctor is advised.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Sinride VM tablet (1mg/500mg/0.2mg) is likely not suitable for use while breastfeeding. Available human evidence indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar irregularities.
KidneyUNSAFE
Sinride VM 1mg/500mg/0.2mg sustained-release tablets are likely unsafe for individuals with kidney impairment and should be omitted. Medical advice is recommended. Furthermore, this medication is contraindicated in patients experiencing severe kidney disease.
LiverCAUTION
Patients with liver impairment should use Sinride VM 1mg/500mg/0.2mg Tablet SR cautiously, as dose modification may be necessary. Individuals with mild to moderate liver disease should begin with a low Sinride VM 1mg/500mg/0.2mg Tablet SR dosage. The medication is contraindicated in patients with severe hepatic dysfunction. Medical advice is recommended.
What if you forget to take Sinride VM 1mg/500mg/0.2mg Tablet SR :
Should you forget to take a Sinride VM 1mg/500mg/0.2mg SR Tablet, administer it immediately upon remembrance. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Sinride VM 1mg/500mg/0.2mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Medication |
3,018 People bought this recently